1. Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer
   Dakui Luo et al, 2020, Journal of Cellular Physiology CrossRef
2. Orabase-formulated gentian violet effectively improved oral potentially malignant disorder in vitro and in vivo
   Yen Yun Wang et al, 2020, Biochemical Pharmacology CrossRef
3. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer
   Carlos Vela-Rodríguez et al, 2022, Biochemical Society Transactions CrossRef
4. DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis
   Liang Chen et al, 2024, Biochemical Genetics CrossRef
5. ADP-Ribosylation of the Ubiquitin C-Terminus by Dtx3L/Parp9
   Teddy Kamata et al, 2019, Ubiquitin Proteasome System - Current Insights into Mechanism Cellular Regulation and Disease CrossRef
6. DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer
   Shan Lin, 2023, Biochemical and Biophysical Research Communications CrossRef
7. Differential MicroRNA Expression Involved in Endometrial Receptivity of Goats
   Xupeng Zang et al, 2021, Biomolecules CrossRef
8. DTX3L/ARTD9 contributes to inflammation of fibroblast-like synoviocytes by increasing STAT1 translocation
   Ruilong Hong et al, 2020, Tissue and Cell CrossRef
9. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway
   Wei Hu et al, 2023, International Journal of Molecular Sciences CrossRef
10. Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease
    Lidong Wang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
11. Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains
    Carlos Vela-Rodríguez et al, 2023, SLAS Discovery CrossRef